Satellite imaging technology to detect the early signs of glaucoma and Alzheimer’s disease in the retina
- Research Opportunity
- PhD, Masters by Research, Honours, Master of Biomedical Science
- Project Status
- Surgery, Otolaryngology, Royal Victorian Eye and Ear Hospital
|Dr Peter van Wijngaarden||Personal web page|
We aim to be the first group in the world to bring hyperspectral imaging, based on NASA satellite technology, to the clinic to improve the care of Australians with glaucoma and Alzheimer’s disease. There are no screening tests for the earliest stages of the diseases. 400,000 Australians live with dementia and most have Alzheimer’s disease. Abnormal proteins accumulate in the brain and retina for 10-20 years before memory impairment, providing an opportunity for early detection and treatment. There are no screening tests for the earliest stages of the disease. Similarly, glaucoma is a leading cause of vision loss affecting 300,000 Australians. Early treatment can save vision, but late diagnosis is typical. The deposition of abnormal proteins in the retina in Alzheimer’s disease and structural changes in the nerve cells affected by glaucoma scatter light in characteristic ways which we can detect with our camera during the early stages of disease. Students with an interest in mathematics and computing are welcome to apply.
This project is conducted in Centre for Eye Research Australia, Diabetic Retinopathy and Neuroglial Interactions Group.
Faculty Research Themes
School Research Themes
PhD, Masters by Research, Honours, Master of Biomedical Science Graduate Research Students who are interested in joining this project will need to consider their elegibility as well as other Graduate Research requirements before contacting the supervisor of this research
For further information about this research, please contact a supervisor.